Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chimera Antigen Receptor (CAR)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05474378
What this trial is testing

B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Nervous System
Stanford University 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT04499573
What this trial is testing

Bispecific CD19/CD22 CAR-T for Treatment of Children and Young Adults With r/r B-ALL

Who this might be right for
B-ALL
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 50
Very early researchNot Yet RecruitingNCT07185490
What this trial is testing

IASO104 for the Treatment of Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma (RRMM)Plasma Cell Leukemia (PCL)
Institute of Hematology & Blood Diseases Hospital, China 40
Early research (Phase 1)Looking for participantsNCT05705570
What this trial is testing

Clinical Trial Using CAR- T Cells for Treatment of Patients With Refractory or Relapsed CD19-positive B Lymphoid Malignancies

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia RefractoryB-cell Lymphoma Recurrent+3 more
Nelson Hamerschlak 30
Early research (Phase 1)Study completedNCT03851146
What this trial is testing

Anti-Lewis Y Chimeric Antigen Receptor-T Cells (LeY-CAR-T) in Patients With Solid Tumours

Who this might be right for
Advanced Cancer
Peter MacCallum Cancer Centre, Australia 20
Early research (Phase 1)UnknownNCT04660929
What this trial is testing

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Who this might be right for
HER2-positiveAdenocarcinomaBile Duct Cancer+28 more
Carisma Therapeutics Inc 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT02690545
What this trial is testing

Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL

Who this might be right for
LymphomaLymphoma, Non-HodgkinImmune System Diseases+5 more
UNC Lineberger Comprehensive Cancer Center 38
Early research (Phase 1)UnknownNCT05727683
What this trial is testing

CD19-targeted CAR T Cells for Patients With Relapsed or Refractory in B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphocytic Leukemia
Shanghai Ming Ju Biotechnology Co., Ltd. 33
Early research (Phase 1)Looking for participantsNCT06612645
What this trial is testing

Safety and Efficacy of CMD03 CAR T Cell in Children With Relapse or Refractory Solid Tumors

Who this might be right for
Pediatric CancersSolid Tumor Pediatric
Chulalongkorn University 9
Early research (Phase 1)UnknownNCT04385173
What this trial is testing

Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma

Who this might be right for
Recurrent GlioblastomaRefractory Glioblastoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 12
Not applicableUnknownNCT05190653
What this trial is testing

Early Integration of Palliative and Supportive Care in Cellular Therapy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+3 more
Alberta Health Services, Calgary 152
Early research (Phase 1)Study completedNCT04768608
What this trial is testing

PD1 Integrated Anti-PSMA CART in Treating Patients With Castrate-Resistant Prostate Cancer

Who this might be right for
Castrate-Resistant Prostate Cancer
Zhejiang University 3
Testing effectiveness (Phase 2)UnknownNCT05117138
What this trial is testing

Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerHead and Neck Squamous Cell Carcinoma
Beijing Immunochina Medical Science & Technology Co., Ltd. 39
Testing effectiveness (Phase 2)Looking for participantsNCT06462248
What this trial is testing

Anti-CD19 Chimeric Antigen Receptor Modified T-cell (CAR-T) Therapy for Treatment of B-cell Hematological Malignancies

Who this might be right for
Lymphoma, NonhodgkinLeukemia, Lymphocytic
Chi Kong Li 20
Testing effectiveness (Phase 2)Looking for participantsNCT06132711
What this trial is testing

Safety and Efficacy of APRIL-BAFF-Bicephali CAR-T in Relapsed, Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Xuzhou Medical University 20
Testing effectiveness (Phase 2)UnknownNCT02862704
What this trial is testing

MG7 Redirected Autologous T Cells for Advanced MG7 Positive Liver Metastases(MG7-CART)

Who this might be right for
Liver Metastases
Xijing Hospital 20
Not applicableLooking for participantsNCT07059741
What this trial is testing

Integrated Radiotherapy-optimized ASCT Sequential CAR-T Therapy for Patients With Relapsed and Refractory B-NHL

Who this might be right for
Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)
The First Affiliated Hospital of Soochow University 20
Early research (Phase 1)UnknownNCT04888442
What this trial is testing

Phase I Study of pCAR-19B in the Treatment of Adult CD19-positive Relapsed/Refractory B-ALL

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseRefractory Acute Lymphoblastic Leukemia
Chongqing Precision Biotech Co., Ltd 18
Early research (Phase 1)Active Not RecruitingNCT06333483
What this trial is testing

Obe-cel in Adolescent [Applicable in UK Only] and Adult Severe, Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Autolus Limited 16
Not applicableLooking for participantsNCT06866873
What this trial is testing

CD-19 CAR-T Cell for Pediatric ALL or Lymphoma

Who this might be right for
Lymphoma, B-CellAcute Lymphoblastic Leukemia, Pediatric
Hong Kong Children's Hospital 18
Next Page